KMTS — Kestra Medical Technologies Cashflow Statement
0.000.00%
Last trade - 00:00- $1.20bn
- $1.18bn
- $27.81m
Annual cashflow statement for Kestra Medical Technologies, fiscal year end - April 30th, USD millions except per share, conversion factor applied.
2020 April 30th | 2021 April 30th | 2023 April 30th | 2024 April 30th | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -29.5 | -34.1 | -84.2 | -94.1 |
| Depreciation | ||||
| Deferred Taxes | ||||
| Non-Cash Items | 0.706 | 3.81 | 8.49 | 5.92 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | -2.01 | -0.019 | 1.3 | 4.39 |
| Change in Accounts Receivable | ||||
| Change in Prepaid Expenses | ||||
| Change in Other Assets | ||||
| Change in Accounts Payable | ||||
| Change in Accrued Expenses | ||||
| Cash from Operating Activities | -30.3 | -29.9 | -69.6 | -72.2 |
| Capital Expenditures | -0.232 | -0.336 | -13.9 | -12.2 |
| Purchase of Fixed Assets | ||||
| Other Investing Cash Flow Items | 0 | 0.002 | -1.53 | -0.003 |
| Sale of Fixed Assets | ||||
| Sale/Maturity of Investment | ||||
| Purchase of Investments | ||||
| Cash from Investing Activities | -0.232 | -0.334 | -15.5 | -12.2 |
| Financing Cash Flow Items | -0.183 | -1.52 | -0.671 | -3.15 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 30.2 | 48.8 | 96.1 | 77.7 |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | -0.286 | 18.6 | 11 | -6.74 |